MRK vs. NVO
Compare and contrast key facts about Merck & Co., Inc. (MRK) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or NVO.
Correlation
The correlation between MRK and NVO is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRK vs. NVO - Performance Comparison
Key characteristics
MRK:
-1.20
NVO:
-0.70
MRK:
-1.57
NVO:
-0.82
MRK:
0.78
NVO:
0.89
MRK:
-0.76
NVO:
-0.57
MRK:
-1.69
NVO:
-1.24
MRK:
16.42%
NVO:
21.47%
MRK:
23.24%
NVO:
38.04%
MRK:
-68.62%
NVO:
-71.32%
MRK:
-31.69%
NVO:
-39.82%
Fundamentals
MRK:
$226.40B
NVO:
$369.14B
MRK:
$6.74
NVO:
$3.16
MRK:
13.28
NVO:
27.87
MRK:
0.07
NVO:
1.28
MRK:
$64.17B
NVO:
$290.40B
MRK:
$51.88B
NVO:
$245.88B
MRK:
$26.73B
NVO:
$148.56B
Returns By Period
In the year-to-date period, MRK achieves a -10.03% return, which is significantly lower than NVO's 2.39% return. Over the past 10 years, MRK has underperformed NVO with an annualized return of 8.13%, while NVO has yielded a comparatively higher 16.39% annualized return.
MRK
-10.03%
-6.46%
-22.11%
-28.87%
5.84%
8.13%
NVO
2.39%
9.32%
-35.69%
-28.49%
24.54%
16.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. NVO — Risk-Adjusted Performance Rank
MRK
NVO
MRK vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRK vs. NVO - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.49%, more than NVO's 1.64% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.49% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
NVO Novo Nordisk A/S | 1.64% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
MRK vs. NVO - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, roughly equal to the maximum NVO drawdown of -71.32%. Use the drawdown chart below to compare losses from any high point for MRK and NVO. For additional features, visit the drawdowns tool.
Volatility
MRK vs. NVO - Volatility Comparison
The current volatility for Merck & Co., Inc. (MRK) is 11.65%, while Novo Nordisk A/S (NVO) has a volatility of 13.94%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRK vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities